SLBT — SL Science Holding Ltd

—
Nasdaq · Health Care · Biotechnology · CIK 2070534 · Taiwan
Last close
$0.64
Market Cap
$356.14M
52W High
$14.50
52W Low
$0.62
ADV30
52,678
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 8,911,138 8,306,692 1,940,448
Dec 2025 — — — — 2,817,180 1,258,616 533,277
Jun 2025 — — — — 5,791,578 3,373,292 1,061,102

Balance + Analyst (yfinance extras)

Retained Earnings
$-7,646,583
Inventory
$73,267
Receivables
$164,285
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,270,101
EBITDA
$-2,284,772
Free Cash Flow
$372,344
Enterprise Value
$4,502,877
Total Cash
$3,373,292
Total Debt
$305,669
Shares Out
560,759,757
Trailing EPS
$-0.01
Book Value
$1.29
ROE
-25.6%
ROA
-14.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,197,249 -3,837,488 -3,819,818 2,817,180 533,277 2,283,903 -1,909,796
Dec 2024 3,363,603 -1,196,111 -1,191,333 5,931,952 204,899 5,727,053 280,158
Dec 2023 878,971 96,828 399,035 4,241,910 668,066 3,573,844 -2,454,261

Peers — same industry

TickerNameMarket CapLastDaily %
JSPR Jasper Therapeutics, Inc. $344.06M $10.34 —
ALEC Alector, Inc. $381.13M $2.56 —
CCCC C4 Therapeutics, Inc. $332.23M $2.53 —
TECX Tectonic Therapeutic, Inc. $392.55M $20.08 —
XFOR X4 Pharmaceuticals, Inc $315.53M $3.09 —

News headlines (Yahoo Finance, 1h cache)

SL Science Holding Limited Reports First Half 2026 Financial Results
2026-10-26 20:15 · Yahoo
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
2026-09-24 12:00 · Yahoo
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
2026-08-27 12:00 · Yahoo
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall
2026-08-18 17:13 · Yahoo
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
2026-08-11 12:00 · Yahoo
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
2026-07-17 12:00 · Yahoo
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
2026-07-10 12:00 · Yahoo
Top Midday Decliners
2026-06-22 18:06 · Yahoo
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
2026-09-02 20:10 · Yahoo
SL Science Holding Limited Reports Full Year 2025 Financial Results
2026-06-18 21:13 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.